RegCell, Inc., a biotechnology company developing first-in-class therapies for autoimmune diseases and transplantation with its epigenetic reprogramming platform leveraging the natural biology of ...

ASX pharmaceutical companies are retaining their assets longer and advancing them to commercialisation in a bid to maximise ...